Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

The Peds Obesity Study

15. Juni 2018 aktualisiert von: University of Florida

Partial Meal Replacements Providing High Protein, Restricted Carbohydrates in the Treatment of Adolescents With Severe Obesity: A Randomized Controlled Trial

The aim of the study is to investigate, in severely obese adolescents, the effects of a high protein, restricted carbohydrates utilizing partial meal replacements diet (HPRC-PMR) on weight loss, body composition, and bio-chemical markers of lipid metabolism, insulin resistance, and inflammation over a 12 months period.

Studienübersicht

Status

Abgeschlossen

Detaillierte Beschreibung

Severely obese adolescents (13 to 17 year old males and post-menarcheal females between the ages of 12 and 17) will be recruited through the University of Florida Health Pediatric Weight Management Center. Therefore, all these patients would have undergone a multifaceted assessment that is part of the standard of care at the University of Florida Pediatric Weight Management Center. This includes a behavioral assessment conducted by the Center's psychologist, a detailed medical history and physical examination as well as a comprehensive laboratory testing to investigate for obesity comorbidities as indicated clinically for the individual patient. These laboratory tests include but not limited to the following: Complete Blood Count, comprehensive metabolic panel, liver enzymes, thyrotropin, fasting plasma glucose and insulin levels, fasting lipid profile and urinalysis. In addition, as part of the standard of care at the University of Florida Pediatric Weight Management Center, patients and families complete the Obesity and Quality of Life questionnaires as well as the University of Florida Pediatric Weight Management Center Physical Activity questionnaire. Inclusion criteria include adolescents with primary obesity and a BMI≥ 99th percentile for age. Exclusion criteria include current diagnosis of Type II Diabetes Mellitus; gall bladder, liver or renal disorders; known eating disorders; known endocrine disorders such as hypothyroidism or polycystic ovary syndrome; pregnancy; genetic disorder, such as Prader-Willi Syndrome; mental retardation; severe depression; or use of any chronic medication that could impact appetite significantly. Patients with poor family support that might potentially preclude compliance with the study requirements will also be excluded. These diseases will be ruled out by means of medical history, physical examination and standard of care laboratory tests obtained on patients upon their entry to the University of Florida Health Pediatric Weight Management Center. A urine pregnancy test will be performed on female adolescents prior to enrolment in the study. Written informed consent will be obtained from the parent and assent from the adolescent.

These patients will participate in a high protein, restricted carbohydrates utilizing partial meal replacements diet (HPRC-PMR) after obtaining consent to participate in the study.

Behavioral counseling will be provided to all participants in the study. The behavior modification used as part of the standard of care at the University of Florida Health Pediatric Weight Management Center includes a combination of immediate, short-term, and long-term individual and family psychotherapy sessions to increase motivation to change diet and physical activity level. These treatments may also help children cope with the emotional stresses associated with being overweight and boost confidence especially within the school system. Obesity and Quality of Life survey will be completed by patients at baseline, and at 3, 6 and 12 months after enrollment. (Permission to use this survey in the Center was obtained from Obesity and Quality of Life Consulting, Durham, North Carolina, and Children's Hospital Medical Center, OH). The survey includes questions regarding physical comfort, body esteem, social life and family relations.

Patients on the HPRC-PMR diet will follow 4 phases. Please see attached table for details.

The minimum amount of protein intake should be 1 g/Kg of protein/day. All meats and fish are permitted in this phase. Lean meats should be chosen. Patients will be encouraged to avoid hunger by having meals and 3 snacks throughout the day.

Enrolled participants will have scheduled meetings with the dietitian. The schedule involves weekly meetings for the first 2 months, then every other week for additional 4 months, followed by monthly meeting for additional 6 months for each patient/family.

Participants will be encouraged via the scheduled meetings with the dietitian to manage expected slip-ups. Minor, inconsequential slip-ups usually occur when the patient is not eating at home. In these cases, patients are encouraged to avoid carbohydrates, or starchy foods and desserts. In these cases, there will be no consequences, as long as these meals don't become a habit should go back to their regular diet the next day. A major diet slip-up is a big meal with all the trimmings. Patient will be encouraged to make up for a major diet slip-up the next day by avoiding all simple and complex carbohydrates for that one day only.

All participants will be encouraged to have "break day" in the maintenance phase. It is a day where the patient goes "all-out" and enjoys whatever foods they feel like eating! Dieters who have struggled with his/her weight and beef, poultry, pork or veal in place of the meal replacement at lunch.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

12

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Florida
      • Jacksonville, Florida, Vereinigte Staaten, 32207
        • University of Florida Pediatric Weight Management Center

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

12 Jahre bis 17 Jahre (Kind)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Severely obese adolescents (13 to 17 year old males and post-menarcheal females between the ages of 12 and 17) will be recruited through the UF Health Pediatric Weight Management Center.
  • All patients would undergo a multifaceted assessment that is part of the standard of care at the UF Pediatric Weight Management Center. (This includes a behavioral assessment conducted by the Center's psychologist, a detailed medical history and physical examination as well as a comprehensive laboratory testing to investigate for obesity comorbidities as indicated clinically for the individual patient. These laboratory tests include but not limited to the following: CBC, comprehensive metabolic panel, liver enzymes, thyrotropin, fasting plasma glucose and insulin levels, fasting lipid profile and urinalysis.)
  • As part of the standard of care at the UF Pediatric Weight Management Center, patients and families complete the IWQOL (Obesity and Quality of Life) questionnaires as well as the UF Pediatric Weight Management Center Physical Activity questionnaire.
  • Adolescents with primary obesity and a BMI≥ 99th percentile for age.

Exclusion Criteria:

  • Current Diagnosis of Type II Diabetes Mellitis
  • Gall Bladder, Renal or Liver Disorders
  • Known Eating Disorders
  • Known Endocrine Disorders (such as hyperthyroidism or polycystic ovary syndrome)
  • Pregnancy
  • Genetic disorder (such as Prader-Willi Syndrome)
  • Mental Retardation
  • Severe Depression
  • Use of any chronic medicine which could impact appetite

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Grundlegende Wissenschaft
  • Zuteilung: Nicht randomisiert
  • Interventionsmodell: Einzelgruppenzuweisung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Aktiver Komparator: Male High Protein, Restricted Carbo, Partial Meal Replacement
A high protein, restricted carbohydrates diet that utilizes partial meal replacements
The use of partial meal replacements will be utilized in conjunction with a high protein, restricted carbohydrate diet
Aktiver Komparator: Female High Protein, Restricted Carbo, Partial Meal Replaceme
A high protein, restricted carbohydrates diet that utilizes partial meal replacements
The use of partial meal replacements will be utilized in conjunction with a high protein, restricted carbohydrate diet

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Improvement in BMI-Z Scores
Zeitfenster: 12 months
BMI measurements will be taken at all appointments for 12 months to track improvement in BMI
12 months
Weight Loss
Zeitfenster: 12 months
Weigh will be obtained at each appointment to track weight loss of 12 months
12 months
Metabolic Abnormalities (Periodic labwork will be obtained over the 12 month period to monitor metabolic abnormalities)
Zeitfenster: 12 months
Periodic labwork will be obtained over the 12 month period to monitor metabolic abnormalities
12 months

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Madeline Joseph, MD, UFJP

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn

1. November 2014

Primärer Abschluss (Tatsächlich)

22. Februar 2018

Studienabschluss (Tatsächlich)

22. Februar 2018

Studienanmeldedaten

Zuerst eingereicht

21. Januar 2015

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

2. Februar 2015

Zuerst gepostet (Schätzen)

3. Februar 2015

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

19. Juni 2018

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

15. Juni 2018

Zuletzt verifiziert

1. Juni 2018

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • UFJ 2014-140
  • IRB201702423 (Andere Kennung: University of Florida)

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

UNENTSCHIEDEN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Partial Meal Replacements

Abonnieren